Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jun 20;11:100117. doi: 10.1016/j.obpill.2024.100117

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Authors

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Fig. 5 — Visual analogue scale (VAS) results for cravings for food and cravings for sugary food throughout the day in response to placebo, low dose (LD) and high dose (HD) Amarasate® treatments. Changes (Δ) in the ratings of (a) cravings for food and (c) cravings for sugary food. Histograms show AUCΔ0–510 min for Δ with respect to (a) cravings for food and (c) cravings for sugary food. Values are means ± standard error of the means (SEMs); n = 27. Treatment capsules were administered at t = 0 min and t = 240 min. Cravings for food exhibited a significant main effect for treatment p < 0.05. Pairwise comparisons: HD vs PLACEBO, ∗p < 0.05, LD vs PLACEBO, ˄ p < 0.05.